Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002287 · ClinicalTrials.gov registry record · NA
A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus
A NA study, sponsored by Glaxo Wellcome.
- Completed
- Registry status
- NA
- Development phase
NCT00002287: Completed NA study, sponsored by Glaxo Wellcome.
NCT00002287 is a NA study that has completed, run by Glaxo Wellcome. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002287, a NA study, has completed, sponsored by Glaxo Wellcome.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the safety and effectiveness of Retrovir (AZT) when used as prophylaxis for health care workers at risk for HIV infection from exposure to HIV-contaminated blood or blood components.
Interventions
- DRUG Zidovudine
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002287 record still lists
NCT00002287 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Zidovudine is the first listed.
NCT00002287 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002287 about?
NCT00002287 is a clinical study titled "A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus". To evaluate the safety and effectiveness of Retrovir (AZT) when used as prophylaxis for health care workers at risk for HIV infection from exposure to HIV-contaminated blood or blood components.
What is the current status of trial NCT00002287?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002287?
The interventions under investigation include: Zidovudine (DRUG).
Who is sponsoring clinical trial NCT00002287?
This trial is sponsored by Glaxo Wellcome, which has 65 total clinical trials registered on ClinicalTrials.gov.